期刊文献+

经直肠B超与前列腺癌特异抗原测定诊断前列腺癌的相关性研究

Correlation study on the transrectaI ultrasound measurements of prostate with prostate specific antigen of the prostate
下载PDF
导出
摘要 目的探讨前列腺癌患者经直肠B超、经直肠活检、血清PSA值测定三者间的相互关系。方法选取经直肠穿刺活检证实为前列腺癌的患者105例,随机分为三组:经直肠超声(TURS)测定组,以前列腺癌患者前列腺声像异常为阳性;血清PSA值测定组,以PSA水平>10ng/L为阳性;TURS与血PSA联合测定组,以TURS前列腺声像异常或PSA水平>10ng/L为阳性;进行三组之间的相关性分析。结果 TURS组阳性率为68.6%,血PSA组阳性率为74.3%,TURS或血清PSA组阳性率为91.4%;TURS组或血清PSA组与联合测定组均显著相关(r=0.398,P<0.01),而TURS组与血PSA组比较无相关性(r=0.254,P>0.05)。结论 TURS和血PSA测定是诊断前列腺癌的一种有价值的检查方法,TURS与血清PSA测定联合应用更能够提高前列腺癌的诊断率。 Objective To assess the correlartion of transrectaI ultrasound measurements of prostate with prostate specific antigen,the rectum biopsy of the prostate.Methods select the rectum biopsy for prostate cancer patients with confirmed the 105 cases were randomly divided into three groups.The transrectal ultrasound(TURS) test group to prostate cancer patients tested positive for prostate ultrasonic wave anomalies.Determination of PSA value group to PSA10ng/L for positive.TURS and blood PSA combined determination group to prostate ultrasonic wave abnormal or PSA10ng/L for positive.The correlation between the three groups were analyzed.ResultsThe positive rate of TURS group was 68.6%,PSA group was 74.3%,TURS and blood PSA combined determination group was 91.4%.TURS group or PSA group and TURS and blood PSA combined determination group(r= 0.398,P 0.01) were significantly associated,but TURS group and PSA group(r=0.254,P0.05),without relevance.Conclusion TURS and blood PSA determination is a kind of diagnosing prostate cancer screening method of value,TURS and PSA determination combined application of more can improve prostate cancer diagnosis rate.
出处 《贵州医药》 CAS 2011年第7期596-598,共3页 Guizhou Medical Journal
关键词 前列腺癌 经直肠超声 血清PSA 诊断 Transrectal ultrasound Prostate specific antigen Protate cancer
  • 相关文献

参考文献10

  • 1American Cancer Society. Cancer Facts & Figures 2010. Atlanta, Ga: American Cancer Society; 2010. 被引量:1
  • 2Catalona WJ. Management of cancer of the prostate[J]. N Engl Med,1994, 331:996-1004. 被引量:1
  • 3Jacobsen S J, Katusic SK, Bergstralh EJ, et al. Incidence of prostate cancer diagnosis in the eras before and after serum prostate-specific antigen testing[J]. Ama,1995, 274: 1445-1449. 被引量:1
  • 4Epstein JI, Potter SR. The pathological interpretation and significance of prostate needle biopsy findings: implications and current controversies[J]. Urol,2001,166: 402-410. 被引量:1
  • 5Lee F ,Torp-pederson ST, Tittrup PJ, et al. Hypoechoic lesions of the prestate: Clinical relevance of tumor size, digital rectal examination and prostate specific antigen [J]. Radiology, 1989,170(1) : 29-33. 被引量:1
  • 6Lee F, Torp-Pedern ST, Mclesry RD. Diagnosis of prostate cancer by transrectal ultrasound[J]. Urol Clin North Am, 1989,16(4):663-666. 被引量:1
  • 7Aus G,Bergdahl S, Lodding P, et al. Prostate cancer screening decrease the absolute risk of being diagnosed with advanced prostate cancer results from a prospective population based randomized controlled trial[J]. Eur Uroh 2007, 51: 659-664. 被引量:1
  • 8Etzioni R,Gulati R,Falcon S,et al. Impact of PSA screen ing on the incidence of advanced stage prostate cancer in the United States: a surveillance modeling approach [J]. Med Decis Miking, 2008,28 : 323-331. 被引量:1
  • 9那彦群..中国泌尿外科疾病诊断治疗指南手册 2009版[M].北京:人民卫生出版社,2009:300.
  • 10Schroder FH, Bangma CH, Roobol MJ. Is it necessary to detect all prostate cancer in men with serum PSA levels < 3. 0ng/ml comparison of biopsy results of PSPT and outcome related information from ERSPC [J]. Eur Urol, 2008,53,901-908. 被引量:1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部